Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-of-1 stimulant versus placebo trial in children with traumatic brain injury
ACTRN12609000865213Phase 3Recruiting
- Sponsor
- Motor Accident Insurance Commission
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of methylphenidate and dextroamphetamine in traumatic brain injury (TBI), sponsored by Motor Accident Insurance Commission. Primary endpoint: Attention, concentration, executive dysfunction, behavioral and emotional regulation. Started Oct 2008; status: recruiting.
02
Drugs
methylphenidatedextroamphetamine
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on ACTRN12609000865213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000865213.